Home | MyCME | All CME | Blog | Psychlopedia

Top 10 CME Activities in the Past Week

  1. Improving the Diagnosis and Treatment of Pediatric Bipolar Disorder

    Findling and Chang

    Pediatric patients with bipolar disorder are at risk for poor long-term outcomes, but with careful screening, clinicians may be able to detect early signs or symptoms. Read this CME Academic Highlights in which experts discuss recognition and diagnosis of bipolar disorder in the pediatric population and options for effective treatment.

  2. Reconsidering Insomnia as a Disorder Rather Than Just a Symptom in Psychiatric Practice

    Ruth M. Benca and Daniel J. Buysse

    Insomnia is often considered a symptom of psychiatric disorders when it actually needs to be addressed as a separate disorder. Read this CME Academic Highlights in which experts discuss ways to evalute patients with insomnia and to safely and effectively implement behavioral and pharmacologic treatments.

  3. Parkinson Disease: Current and Emerging Treatment Strategies

    Adolfo Ramirez-Zamora

    Although levodopa is effective for treating Parkinson disease, physicians and patients face significant management challenges related to disease progression. Patients may develop fluctuations in motor symptoms and dyskinesias as well as nonmotor symptoms. Review this CME Brief Report activity to learn about new and emerging treatment options to manage patients’ symptoms.

  4. Tardive Dyskinesia: Recognition, Patient Assessment, and Differential Diagnosis

    Jain and Correll

    Tardive dyskinesia (TD) is an involuntary movement disorder associated with antipsychotic treatment. Because of the serious and potentially irreversible nature of TD, accurate diagnosis is crucial. However, the risk may be underestimated, and diagnosing TD can be challenging, with early signs easily missed. To learn more, read this ACADEMIC HIGHLIGHTS, in which experts review the prevalence, phenomenology, risk factors, and impact of TD, illustrated by case examples, and provide valuable clinical information to guide early recognition and accurate diagnosis.

  5. Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management

    Larry Culpepper (Chair), et al

    Is cognitive impairment keeping your patients with MDD from achieving full functional recovery? In this Academic Highlights, leading experts in MDD discuss the burden associated with cognitive impairment, effective strategies for assessing cognitive function, and available pharmacologic and nonpharmacologic treatment options.

  6. Diagnosing and Treating Patients With Mixed Features

    Rakesh Jain (Chair) et al

    Descriptions of mixed states can be found in the writings of ancient Greek physicians, and the concept continues to be refined. In this CME activity, join experts as they review the current diagnostic criteria for depressive episodes with mixed features, the risk of developing bipolar disorder in patients with this diagnosis, and recent treatment guidelines.

  7. A Retrospective Comparative Effectiveness Study of Medications for Posttraumatic Stress Disorder in Routine Practice

    Shiner et al

    How do treatments for posttraumatic stress disorder (PTSD) compare in routine clinical practice? Read this CME retrospective study of patient records for a look at real-life outcomes. Patients were taking fluoxetine, paroxetine, sertraline, topiramate, or venlafaxine, and some had concurrent psychotherapy.

  8. Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan?

    Correll and Lauriello

    Long-acting injectable (LAI) antipsychotics have the potential to improve adherence and outcomes for patients with serious mental illness but are underused. Watch this Webcast to learn how to identify patients who may benefit from using LAIs, monitor LAI treatment adherence, and use LAIs safely and effectively in patients with schizophrenia and related disorders.

  9. Evidence-Based Strategies for Managing Tardive Dyskinesia

    Joseph P. McEvoy

    Do you know how to treat tardive dyskinesia symptoms? In this new Case and Comment activity, consider the case of John, a 25-year-old project manager diagnosed with bipolar disorder who has begun exhibiting symptoms of uncontrollable movement.

  10. Treating Bipolar Disorder in Adolescents

    Robert L. Findling

    How do you select among treatments for bipolar disorder in adolescents? Check out this brief report activity to explore the efficacy and safety of lithium, anticonvulsants, and atypical antipsychotics in the treatment of adolescent bipolar disorder. Plus, receive guidance for monitoring for common adverse effects, such as weight gain and fatigue.